Share prices for HandHeld Entertainment (NASDAQ: ZVUE) rose 23 percent today after the company announced the release of its new “value-priced” MP3 video player, the ZVUE 260.According to the announcement, the ZVUE 260 is a…
Shares of Dynacq Healthcare Inc. (Nasdaq: DYII) skyrocketed today after its earnings release surfaced. In mid-day trading, DYII was up $4.35 (176 percent) to $6.81 per share on volume of just over 1.4 million shares.…
Shares of PreMD Inc. (AMEX: PME) steadily rose in Monday’s trading, settling at $1.90, up 82 cents or 76 percent, at the market’s close. The move follows PreMD’s news it struck a deal with AstraZeneca…
Shares of Dynacq Healthcare Inc. (Nasdaq: DYII) skyrocketed today after its earnings release surfaced. In mid-day trading, DYII was up $4.71 (191 percent) to $7.17 per share on volume of just over 1 million shares.…
Shares of Dyax Corporation (Nasdaq: DYAX) jumped up today after news about the pricing of its $40 million public offering through UBS surfaced. In early trading today, DYAX was up 33 cents (9 percent) to…
Shares of Dyax Corporation (Nasdaq: DYAX) jumped up today after news about the pricing of its $40 million public offering through UBS surfaced. In early trading today, DYAX was up 33 cents (9 percent) to…
Shares of SBE Inc. (Nasdaq: SBEI) skyrocketed up the charts yesterday after news of its merger with Neonode was included in a press release issued by Neonode. Shares closed up $5.09 (179 percent) at $7.94…
Pressure BioSciences is focused on developing its technology which uses hydrostatic pressure to control bio-molecular interactions. The company holds 17 patents which cover various applications. To prepare for a rise in demand, Pressure BioSciences has…
SigmaTel Inc. (NASDAQ: SGTL) announced today a revision in its financial outlook for June 2007. SigmaTel expects that revenue for the second quarter will now be in the range of $30 million to $31 million,…
SigmaTel Inc. (NASDAQ: SGTL) announced today a revision in its financial outlook for June 2007. SigmaTel expects that revenue for the second quarter will now be in the range of $30 million to $31 million,…
SigmaTel Inc. (NASDAQ: SGTL) announced today a revision in its financial outlook for June 2007. SigmaTel expects that revenue for the second quarter will now be in the range of $30 million to $31 million,…
Shares of Transmeta (Nasdaq: TMTA) were up 20 cents, or 28 percent, to 90 cents on volume of nearly 8 million this morning, reeling from yesterday’s news of a multi-million dollar investment.Advanced Micro Devices Inc.…
Newtek Business Services, Inc. (Nasdaq: NEWT) recently reported that its electronic payment processing division, under the Newtek(TM) brand, has entered into a merchant acquiring agreement with Discover Financial Services, a business unit of Morgan Stanley…
It wasn’t such a bright day for Movie Gallery (Nasdaq: MOVI) as shares continued to slide down the charts. At the close yesterday, shares were down $1.23, or 65 percent, to 66 cents on volume…
Shares for Quaker Fabric Corporation (NASDAQ: QFAB) dropped like a stone today, plunging more than 80 percent on market open. The source of the drop was a statement the company released after market closed yesterday…
Avanir Pharmaceuticals (Nasdaq: AVNR) shares are trading at $2.76 on volume of 4.1 million this morning, up 38 cents from yesterday’s close, following word of the company’s $42 million sale of its anti-psychotic drug, FazaClo.…
BarChart is one of the largest suppliers of delayed futures market data in addition to supplying Real-time Data, Quotes, Charts, Technical Analysis, Newsletters, and Computer Applications to investors. Since its beginning in 1934 as the…
Nutrition 21, Inc. is Set to Present at the RedChip Small Cap Conference Next Month in New York City. The Company is involved in research and product development aimed to help diabetics. Recently, Nutrition 21,…
Share prices for MRV Communications (NASDAQ: MRVC) tumbled more than 13 percent this morning after the company announced along with its subsidiary, Luminent Inc., has closed on its previously acquired company Fiberxon.According to the press…
Optibase Ltd. (NASDAQ: OBAS) proved itself an up-and-coming contender in the video solutions industry last week after it announced its latest multi-platform project at Vancouver International Airport in Vancouver, Canada.According to the press release, the…
VistaGen Therapeutics, Inc., an emerging biopharmaceutical company, focused on stem cell technologies, to discover, develop and commercialize novel small molecule drugs and protein therapeutics for neurological disorders and diabetes, announced positive results from preclinical studies…
VistaGen Therapeutics Inc., a biopharmaceutical company pioneering the use of embryonic stem cells as proprietary biological systems for discovery and development of novel drugs for the treatment of diabetes and neurological diseases, announced today three…
VistaGen Therapeutics, Inc., a biopharmaceutical company developing drugs for treating neurological disorders and diabetes, announced today positive preclinical data supporting expanded applications of AV-101, the Company’s first in-class prodrug that regulates critical NMDA receptors in…
VistaGen Therapeutics, Inc., a biopharmaceutical company pioneering the use of embryonic stem cells as proprietary biological systems for discovery and development of novel drugs for the treatment of diabetes and central nervous system disorders, announced…
VistaGen Therapeutics Inc., a biopharmaceutical company applying leading embryonic stem cell technology to discover and develop novel treatments for central nervous system disorders, diabetes and cardiovascular disease, and Cato BioVentures, the venture capital affiliate of…
Congressman Tom Lantos (D-San Francisco, San Mateo) speaking from the laboratories of VistaGen Therapeutics, a biopharmaceutical company, affirmed his support of the expansion of stem cell research using human embryos that would otherwise become medical…
VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics using embryonic stem cell technologies, announced today that the High Q Foundation, Inc. has agreed…
VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics for Central Nervous System (CNS) and Peripheral Nervous System (PNS) disorders and metabolic diseases using…
Burlingame, CA, May 24, 2005 /PRNewswire/ — VistaGen Therapeutics, Inc., a development stage biopharmaceutical company focused on discovering, developing and commercializing novel small molecule and protein therapeutics for Central Nervous System (CNS) disorders and metabolic…